| (+)-catechin | decreases activity | EXP | | 6480464 | Catechin results in decreased activity of CYP19A1 protein | CTD | PMID:18534843 |
| (-)-epigallocatechin 3-gallate | decreases activity | ISO | RGD:737520 | 6480464 | epigallocatechin gallate results in decreased activity of CYP19A1 protein | CTD | PMID:14600287 |
| (S)-naringenin | multiple interactions | ISO | RGD:1606587 | 6480464 | naringenin binds to and results in decreased activity of CYP19A1 protein | CTD | PMID:9435150 |
| (S)-naringenin | decreases activity | EXP | | 6480464 | naringenin results in decreased activity of CYP19A1 protein | CTD | PMID:17895526 |
| (S)-naringenin | decreases activity | ISO | RGD:1606587 | 6480464 | naringenin results in decreased activity of CYP19A1 protein | CTD | PMID:15319488 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:1606587 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane binds to and results in decreased activity of CYP19A1 protein; more ... | CTD | PMID:22120136 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:16737795 PMID:19414516 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases expression | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of CYP19A1 mRNA | CTD | PMID:22120136 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:19414516 PMID:16737795 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases activity | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased activity of CYP19A1 protein | CTD | PMID:22120136 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases expression | ISO | RGD:1606587 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of CYP19A1 mRNA | CTD | PMID:22120136 |
| 1-benzofuran | decreases activity | ISO | RGD:1606587 | 6480464 | benzofuran analog results in decreased activity of CYP19A1 protein | CTD | PMID:15968818 |
| 17beta-estradiol | increases expression | ISO | RGD:1606587 | 6480464 | Estradiol results in increased expression of CYP19A1 mRNA | CTD | PMID:16029874 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1606587 | 6480464 | Estradiol promotes the reaction [ESR2 protein affects the expression of CYP19A1 mRNA] | CTD | PMID:20404318 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1606587 | 6480464 | [Water Pollutants, Chemical results in increased activity of CYP19A1 protein] which results in decreased metabolism of Estradiol | CTD | PMID:20466405 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1606587 | 6480464 | [Atrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Estradiol; more ... | CTD | PMID:20087668 |
| 17beta-estradiol | increases activity | ISO | RGD:1606587 | 6480464 | Estradiol results in increased activity of CYP19A1 protein | CTD | PMID:12839940 PMID:15955695 |
| 17beta-estradiol | affects chemical synthesis | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the chemical synthesis of Estradiol | CTD | PMID:16024248 PMID:16030167 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1606587 | 6480464 | TNF protein promotes the reaction [CYP19A1 protein affects the chemical synthesis of Estradiol] | CTD | PMID:16030167 |
| 17beta-estradiol | increases activity | ISO | RGD:1606587 | 6480464 | Estradiol results in increased activity of CYP19A1 protein | CTD | PMID:15955695 PMID:12839940 |
| 17beta-estradiol | affects expression | ISO | RGD:1606587 | 6480464 | Estradiol affects the expression of CYP19A1 mRNA | CTD | PMID:14699072 |
| 17beta-estradiol | increases chemical synthesis | ISO | RGD:1606587 | 6480464 | CYP19A1 protein results in increased chemical synthesis of Estradiol | CTD | PMID:16054388 |
| 17beta-estradiol | affects chemical synthesis | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the chemical synthesis of Estradiol | CTD | PMID:16030167 PMID:16024248 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1606587 | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Estradiol results in increased activity of CYP19A1 protein]; more ... | CTD | PMID:12839940 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Testosterone results in increased expression of CYP19A1 protein] which results in increased abundance of Estradiol; more ... | CTD | PMID:21273442 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CYP19A1 mRNA | CTD | PMID:18191889 |
| 17beta-estradiol | affects activity | EXP | | 6480464 | Estradiol affects the activity of CYP19A1 protein | CTD | PMID:21068160 |
| 17beta-estradiol | increases chemical synthesis | EXP | | 6480464 | CYP19A1 protein results in increased chemical synthesis of Estradiol | CTD | PMID:16569475 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A results in decreased expression of CYP19A1 mRNA] which affects the abundance of Estradiol | CTD | PMID:18191889 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737520 | 6480464 | Estradiol affects the reaction [CYP19A1 affects the expression of BMP15 mRNA]; more ... | CTD | PMID:11985600 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CYP19A1 mRNA | CTD | PMID:21273442 PMID:15525594 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CYP19A1 mRNA | CTD | PMID:15525594 PMID:21273442 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CYP19A1 protein | CTD | PMID:15525594 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:1606587 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP19A1 mRNA | CTD | PMID:22262711 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | RGD:1606587 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of CYP19A1 mRNA | CTD | PMID:22262711 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1606587 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:19147701 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737520 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:22889882 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:11026553 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:11026553 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 protein | CTD | PMID:20823264 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1606587 | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 protein] | CTD | PMID:20823264 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:11489354 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:11489354 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:19147701 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:16141434 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:11500237 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:19147701 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:19276399 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:16141434 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:15590112 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA | CTD | PMID:11500237 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased activity of CYP19A1 protein | CTD | PMID:16141434 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Gonadotropins, Equine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 mRNA] | CTD | PMID:19276399 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP19A1 mRNA; more ... | CTD | PMID:18284931 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases stability | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased stability of CYP19A1 mRNA | CTD | PMID:19962423 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1606587 | 6480464 | U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in increased stability of CYP19A1 mRNA] | CTD | PMID:19962423 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 protein | CTD | PMID:19962423 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP19A1 protein | CTD | PMID:19962423 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects activity | ISO | RGD:1606587 | 6480464 | Tetrachlorodibenzodioxin affects the activity of CYP19A1 protein | CTD | PMID:12916318 |
| 2,4,6-trichlorophenol | decreases expression | ISO | RGD:1606587 | 6480464 | 2,4,6-trichlorophenol results in decreased expression of CYP19A1 mRNA | CTD | PMID:21296122 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:1606587 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP19A1 mRNA | CTD | PMID:16216300 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:1606587 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP19A1 mRNA | CTD | PMID:16216300 PMID:22262711 |
| 3,3',5,5'-tetrabromobisphenol A | decreases activity | ISO | RGD:1606587 | 6480464 | tetrabromobisphenol A analog results in decreased activity of CYP19A1 protein | CTD | PMID:16177243 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | RGD:1606587 | 6480464 | Am 580 results in increased expression of CYP19A1 mRNA | CTD | PMID:15941851 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:1606587 | 6480464 | decitabine affects the methylation of CYP19A1 promoter | CTD | PMID:17662285 |
| 7-hydroxyflavanone | decreases activity | ISO | RGD:1606587 | 6480464 | 7-hydroxyflavanone results in decreased activity of CYP19A1 protein | CTD | PMID:15319488 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1606587 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA | CTD | PMID:22120136 |
| 8-bromo-3',5'-cyclic AMP | increases activity | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein | CTD | PMID:21126571 PMID:22120136 |
| 8-bromo-3',5'-cyclic AMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 protein | CTD | PMID:21126571 |
| 8-bromo-3',5'-cyclic AMP | increases activity | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein | CTD | PMID:22120136 PMID:21126571 |
| 8-bromo-3',5'-cyclic AMP | increases activity | ISO | RGD:1606587 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein | CTD | PMID:10746939 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; more ... | CTD | PMID:22120136 |
| 8-bromo-3',5'-cyclic AMP | increases activity | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein | CTD | PMID:22120136 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:1606587 | 6480464 | alitretinoin results in increased expression of CYP19A1 mRNA | CTD | PMID:15941851 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:1606587 | 6480464 | alitretinoin inhibits the reaction [NR5A2 protein results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:16357189 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:1606587 | 6480464 | [alitretinoin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | CTD | PMID:15941851 |
| acetaldehyde | multiple interactions | ISO | RGD:737520 | 6480464 | [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of CYP19A1 mRNA | CTD | PMID:22285649 |
| afimoxifene | increases expression | ISO | RGD:1606587 | 6480464 | 4-hydroxytamoxifen results in increased expression of CYP19A1 mRNA | CTD | PMID:19549922 |
| aflatoxin B1 | increases expression | ISO | RGD:1606587 | 6480464 | Aflatoxin B1 results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:21296134 |
| aflatoxin B1 | multiple interactions | ISO | RGD:1606587 | 6480464 | alpha-naphthoflavone inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:21296134 |
| aflatoxin B1 | increases metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein results in increased metabolism of Aflatoxin B1 | CTD | PMID:21296134 |
| albuterol | multiple interactions | ISO | RGD:1606587 | 6480464 | [Cyproterone co-treated with Albuterol] results in decreased expression of CYP19A1 | CTD | PMID:17822730 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1606587 | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of CYP19A1 mRNA | CTD | PMID:16443354 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1606587 | 6480464 | Tretinoin results in increased expression of CYP19A1 mRNA | CTD | PMID:15941851 |
| aminoglutethimide | multiple interactions | ISO | RGD:1606587 | 6480464 | Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the chemical synthesis of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine]; more ... | CTD | PMID:15242824 |
| aminoglutethimide | increases activity | ISO | RGD:1606587 | 6480464 | Aminoglutethimide results in increased activity of CYP19A1 protein | CTD | PMID:20087668 |
| aminoglutethimide | decreases activity | ISO | RGD:1606587 | 6480464 | Aminoglutethimide results in decreased activity of CYP19A1 protein | CTD | PMID:17910019 PMID:15968818 |
| aminoglutethimide | decreases activity | ISO | RGD:1606587 | 6480464 | Aminoglutethimide results in decreased activity of CYP19A1 protein | CTD | PMID:15968818 PMID:17910019 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYP19A1 mRNA | CTD | PMID:16483693 |
| amoxicillin | increases expression | ISO | RGD:1606587 | 6480464 | Amoxicillin results in increased expression of CYP19A1 | CTD | PMID:17822730 |
| amphetamine | decreases response to substance | ISO | RGD:737520 | 6480464 | CYP19A1 gene results in decreased susceptibility to Amphetamine | CTD | PMID:12884966 |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16054421 more ... |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:15837728 more ... |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16023338 more ... |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:15837728 more ... |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16001952 more ... |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16023338 more ... |
| anastrozole | decreases activity | ISO | RGD:1606587 | 6480464 | anastrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16034487 more ... |
| androst-4-ene-3,17-dione | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Androstenedione | CTD | PMID:16033851 more ... |
| androst-4-ene-3,17-dione | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Androstenedione | CTD | PMID:16030167 more ... |
| androst-4-ene-3,17-dione | increases metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein results in increased metabolism of Androstenedione | CTD | PMID:22120136 |
| androst-4-ene-3,17-dione | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Androstenedione | CTD | PMID:16054388 more ... |
| androst-4-ene-3,17-dione | multiple interactions | ISO | RGD:1606587 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [CYP19A1 protein results in increased metabolism of Androstenedione]; more ... | CTD | PMID:22120136 |
| androst-4-ene-3,17-dione | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Androstenedione | CTD | PMID:16033851 more ... |
| androst-4-ene-3,17-dione | increases metabolic processing | EXP | | 6480464 | CYP19A1 protein results in increased metabolism of Androstenedione | CTD | PMID:16569475 |
| androst-4-ene-3,17-dione | multiple interactions | EXP | | 6480464 | bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP19A1 protein]; more ... | CTD | PMID:21273442 |
| androst-4-ene-3,17-dione | increases expression | EXP | | 6480464 | Androstenedione results in increased expression of CYP19A1 mRNA | CTD | PMID:21273442 |
| androst-4-ene-3,17-dione | multiple interactions | ISO | RGD:1606587 | 6480464 | TNF protein promotes the reaction [CYP19A1 protein affects the metabolism of Androstenedione] | CTD | PMID:16030167 |
| androst-4-ene-3,17-dione | multiple interactions | ISO | RGD:1606587 | 6480464 | Methyltestosterone inhibits the reaction [CYP19A1 protein affects the metabolism of Androstenedione]; more ... | CTD | PMID:12628686 |
| androst-4-ene-3,17-dione | multiple interactions | ISO | RGD:1606587 | 6480464 | CYP19A1 protein binds to and results in increased metabolism of Androstenedione; more ... | CTD | PMID:11522339 |
| androst-4-ene-3,17-dione | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Androstenedione | CTD | PMID:12628686 more ... |
| androstane-3,17-diol | increases expression | EXP | | 6480464 | Androstane-3,17-diol results in increased expression of CYP19A1 mRNA | CTD | PMID:21273442 |
| aniline | decreases activity | ISO | RGD:1606587 | 6480464 | aniline analog results in decreased activity of CYP19A1 protein | CTD | PMID:16480277 |
| aniline | decreases expression | ISO | RGD:1606587 | 6480464 | aniline analog results in decreased expression of CYP19A1 mRNA | CTD | PMID:16480277 |
| apigenin | decreases activity | ISO | RGD:1606587 | 6480464 | Apigenin results in decreased activity of CYP19A1 protein | CTD | PMID:10403137 more ... |
| apigenin | decreases activity | ISO | RGD:1606587 | 6480464 | Apigenin results in decreased activity of CYP19A1 protein | CTD | PMID:15319488 more ... |
| apigenin | decreases activity | ISO | RGD:1606587 | 6480464 | Apigenin results in decreased activity of CYP19A1 protein | CTD | PMID:16023337 more ... |
| apigenin | decreases activity | ISO | RGD:1606587 | 6480464 | Apigenin results in decreased activity of CYP19A1 protein | CTD | PMID:16965912 more ... |
| apigenin | decreases expression | ISO | RGD:1606587 | 6480464 | Apigenin results in decreased expression of CYP19A1 mRNA | CTD | PMID:16965912 |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:18461179 more ... |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:22120136 more ... |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | NR5A1 protein promotes the reaction [Atrazine results in increased expression of CYP19A1 mRNA] | CTD | PMID:17331471 |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:10746939 more ... |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | [Atrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone; more ... | CTD | PMID:20087668 |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:10746939 more ... |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:10746939 more ... |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:10746939 more ... |
| atrazine | increases expression | ISO | RGD:737520 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:20723554 |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:22120136 PMID:22285353 |
| atrazine | increases activity | EXP | | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:21126571 |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:18461179 more ... |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:16996190 more ... |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:22285353 PMID:22120136 |
| atrazine | multiple interactions | EXP | | 6480464 | Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; more ... | CTD | PMID:22120136 |
| atrazine | affects expression | EXP | | 6480464 | Atrazine affects the expression of CYP19A1 protein | CTD | PMID:22285353 |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:12127262 more ... |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | Atrazine promotes the reaction [CYP19A1 protein results in increased metabolism of Androstenedione] | CTD | PMID:22120136 |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:18461179 more ... |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:12127262 more ... |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:16996190 more ... |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | SGK1 protein affects the reaction [Atrazine results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:18461179 |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:11675267 more ... |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:11675267 more ... |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine metabolite results in increased expression of CYP19A1 mRNA | CTD | PMID:11675267 |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | formestane inhibits the reaction [Atrazine results in increased activity of CYP19A1 protein] | CTD | PMID:10746939 |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | Atrazine promotes the reaction [[NR5A1 protein binds to CYP19A1 gene] which results in increased expression of CYP19A1 mRNA] | CTD | PMID:17520059 |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine metabolite results in increased activity of CYP19A1 protein | CTD | PMID:11675267 |
| atrazine | increases expression | ISO | RGD:1606587 | 6480464 | Atrazine results in increased expression of CYP19A1 mRNA | CTD | PMID:22120136 more ... |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:16996190 more ... |
| atrazine | multiple interactions | ISO | RGD:1606587 | 6480464 | Atrazine promotes the reaction [[NR5A1 protein binds to CYP19A1 gene] which results in increased expression of CYP19A1 mRNA] | CTD | PMID:17520059 PMID:17520059 |
| atrazine | increases activity | ISO | RGD:1606587 | 6480464 | Atrazine results in increased activity of CYP19A1 protein | CTD | PMID:10746939 more ... |
| benomyl | increases activity | ISO | RGD:1606587 | 6480464 | Benomyl results in increased activity of CYP19A1 protein | CTD | PMID:14691014 |
| benomyl | increases expression | ISO | RGD:1606587 | 6480464 | Benomyl results in increased expression of CYP19A1 mRNA | CTD | PMID:14691014 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP19A1 mRNA; more ... | CTD | PMID:20920559 |
| benzo[a]pyrene | increases expression | ISO | RGD:1606587 | 6480464 | Benzo(a)pyrene results in increased expression of CYP19A1 mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1606587 | 6480464 | Benzo(a)pyrene results in increased expression of CYP19A1 mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CYP19A1 mRNA; more ... | CTD | PMID:20920559 |
| benzo[a]pyrene | increases expression | ISO | RGD:1606587 | 6480464 | Benzo(a)pyrene results in increased expression of CYP19A1 mRNA | CTD | PMID:20064835 PMID:20106945 |
| bezafibrate | decreases activity | ISO | RGD:1606587 | 6480464 | Bezafibrate results in decreased activity of CYP19A1 protein | CTD | PMID:19539015 |
| bezafibrate | multiple interactions | ISO | RGD:737520 | 6480464 | Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACOX1 mRNA]; more ... | CTD | PMID:11929713 |
| bezafibrate | decreases expression | ISO | RGD:1606587 | 6480464 | Bezafibrate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19539015 |
| bicalutamide | multiple interactions | EXP | | 6480464 | bicalutamide inhibits the reaction [Androstenedione results in increased expression of CYP19A1 protein]; more ... | CTD | PMID:21273442 |
| bifenthrin | multiple interactions | EXP | | 6480464 | bifenthrin inhibits the reaction [CGA protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:21251947 |
| biochanin A | multiple interactions | ISO | RGD:1606587 | 6480464 | biochanin A binds to and results in decreased activity of CYP19A1 protein | CTD | PMID:9435150 |
| biochanin A | multiple interactions | ISO | RGD:1606587 | 6480464 | [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein; more ... | CTD | PMID:16965912 |
| biochanin A | decreases expression | ISO | RGD:1606587 | 6480464 | biochanin A results in decreased expression of CYP19A1 mRNA | CTD | PMID:16965912 |
| biochanin A | decreases activity | ISO | RGD:1606587 | 6480464 | biochanin A results in decreased activity of CYP19A1 protein | CTD | PMID:16965912 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP19A1 mRNA; more ... | CTD | PMID:20920559 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:737520 | 6480464 | Diethylhexyl Phthalate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19874833 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:737520 | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate] results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:22828881 |
| bis(2-ethylhexyl) phthalate | affects expression | EXP | | 6480464 | Diethylhexyl Phthalate affects the expression of CYP19A1 mRNA | CTD | PMID:20568448 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of CYP19A1 mRNA | CTD | PMID:16763069 PMID:19560483 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of CYP19A1 mRNA | CTD | PMID:19560483 PMID:16763069 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of CYP19A1 mRNA | CTD | PMID:16763069 |
| bis(2-ethylhexyl) phthalate | increases activity | EXP | | 6480464 | Diethylhexyl Phthalate results in increased activity of CYP19A1 protein | CTD | PMID:16949715 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CYP19A1 mRNA; more ... | CTD | PMID:20920559 |
| bis(2-ethylhexyl) phthalate | decreases activity | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased activity of CYP19A1 protein | CTD | PMID:16949715 |
| bisphenol A | multiple interactions | ISO | RGD:1606587 | 6480464 | bisphenol A affects the reaction [CYP19A1 protein results in increased metabolism of Androstenedione] | CTD | PMID:22120136 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYP19A1 mRNA | CTD | PMID:20096755 more ... |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP19A1 mRNA | CTD | PMID:18191889 more ... |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP19A1 protein | CTD | PMID:22285353 PMID:23405234 |
| bisphenol A | multiple interactions | ISO | RGD:737520 | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate] results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:22828881 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYP19A1 protein | CTD | PMID:20821433 |
| bisphenol A | increases activity | ISO | RGD:1606587 | 6480464 | bisphenol A results in increased activity of CYP19A1 protein | CTD | PMID:12849724 |
| bisphenol A | decreases activity | ISO | RGD:1606587 | 6480464 | bisphenol A results in decreased activity of CYP19A1 protein | CTD | PMID:12849724 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYP19A1 mRNA | CTD | PMID:20096755 |
| bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A results in decreased expression of CYP19A1 mRNA] which affects the abundance of Estradiol | CTD | PMID:18191889 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP19A1 mRNA | CTD | PMID:18191889 |
| bisphenol A | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein]; more ... | CTD | PMID:20096755 |
| bisphenol A | multiple interactions | ISO | RGD:737520 | 6480464 | bisphenol A affects the reaction [CYP19A1 affects the expression of GDF9 mRNA]; more ... | CTD | PMID:11985600 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP19A1 mRNA | CTD | PMID:22120136 PMID:18191889 |
| bisphenol A | increases expression | ISO | RGD:737520 | 6480464 | bisphenol A results in increased expression of CYP19A1 protein; more ... | CTD | PMID:21123812 PMID:21182934 |
| bisphenol A | decreases expression | ISO | RGD:1606587 | 6480464 | bisphenol A results in decreased expression of CYP19A1 mRNA | CTD | PMID:22120136 PMID:22327052 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP19A1 protein | CTD | PMID:22285353 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP19A1 mRNA | CTD | PMID:18191889 PMID:22120136 |
| bisphenol A | multiple interactions | EXP | | 6480464 | bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein] | CTD | PMID:22120136 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CYP19A1 mRNA | CTD | PMID:22285353 |
| bisphenol A | increases expression | ISO | RGD:737520 | 6480464 | bisphenol A results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:21182934 PMID:21123812 |
| bisphenol A | decreases expression | ISO | RGD:1606587 | 6480464 | bisphenol A results in decreased expression of CYP19A1 mRNA | CTD | PMID:22327052 PMID:22120136 |
| bisphenol A | multiple interactions | ISO | RGD:1606587 | 6480464 | bisphenol A inhibits the reaction [FSHB results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:20064783 |
| calcitriol | multiple interactions | ISO | RGD:1606587 | 6480464 | Calcitriol promotes the reaction [Dexamethasone results in increased activity of CYP19A1 protein] | CTD | PMID:15862960 |
| calcitriol | increases expression | ISO | RGD:1606587 | 6480464 | Calcitriol results in increased expression of CYP19A1 mRNA | CTD | PMID:16002434 |
| calcitriol | increases activity | ISO | RGD:1606587 | 6480464 | Calcitriol results in increased activity of CYP19A1 protein | CTD | PMID:15862960 |
| carbendazim | increases expression | ISO | RGD:1606587 | 6480464 | mecarzole results in increased expression of CYP19A1 mRNA | CTD | PMID:14691014 |
| carbendazim | increases activity | ISO | RGD:1606587 | 6480464 | mecarzole results in increased activity of CYP19A1 protein | CTD | PMID:14691014 |
| carmustine | decreases expression | ISO | RGD:1606587 | 6480464 | Carmustine results in decreased expression of CYP19A1 mRNA | CTD | PMID:15980968 |
| celecoxib | decreases activity | ISO | RGD:1606587 | 6480464 | celecoxib results in decreased activity of CYP19A1 protein | CTD | PMID:15964185 |
| celecoxib | decreases expression | ISO | RGD:1606587 | 6480464 | celecoxib results in decreased expression of CYP19A1 mRNA | CTD | PMID:15964185 |
| cis-ketoconazole | increases activity | ISO | RGD:1606587 | 6480464 | Ketoconazole results in increased activity of CYP19A1 protein | CTD | PMID:20087668 |
| clotrimazole | decreases activity | ISO | RGD:1606587 | 6480464 | Clotrimazole results in decreased activity of CYP19A1 protein | CTD | PMID:15554355 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1606587 | 6480464 | Copper Sulfate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19549813 |
| cyanamide | multiple interactions | ISO | RGD:737520 | 6480464 | Cyanamide inhibits the reaction [CGA protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:22285649 |
| cycloheximide | decreases activity | ISO | RGD:1606587 | 6480464 | Cycloheximide results in decreased activity of CYP19A1 protein | CTD | PMID:16480277 |
| cycloheximide | decreases expression | EXP | | 6480464 | Cycloheximide results in decreased expression of CYP19A1 protein | CTD | PMID:21126571 |
| cyclosporin A | decreases expression | ISO | RGD:1606587 | 6480464 | Cyclosporine results in decreased expression of CYP19A1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1606587 | 6480464 | Cyclosporine results in decreased expression of CYP19A1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyhexatin | increases expression | ISO | RGD:1606587 | 6480464 | cyhexatin results in increased expression of CYP19A1 mRNA | CTD | PMID:15941851 |
| cypermethrin | increases activity | ISO | RGD:1606587 | 6480464 | cypermethrin results in increased activity of CYP19A1 protein | CTD | PMID:16996190 |
| cyproterone | multiple interactions | ISO | RGD:1606587 | 6480464 | [Cyproterone co-treated with Albuterol] results in decreased expression of CYP19A1 | CTD | PMID:17822730 |
| daidzein | decreases activity | ISO | RGD:1606587 | 6480464 | daidzein results in decreased activity of CYP19A1 protein | CTD | PMID:16023337 PMID:16965912 |
| daidzein | decreases activity | ISO | RGD:1606587 | 6480464 | daidzein results in decreased activity of CYP19A1 protein | CTD | PMID:16965912 PMID:16023337 |
| daidzein | multiple interactions | ISO | RGD:1606587 | 6480464 | [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein; more ... | CTD | PMID:16965912 |
| daidzein | decreases expression | ISO | RGD:1606587 | 6480464 | daidzein results in decreased expression of CYP19A1 mRNA | CTD | PMID:16965912 |
| DDE | multiple interactions | ISO | RGD:1606587 | 6480464 | [Dichlorodiphenyl Dichloroethylene co-treated with FSHB protein] results in increased activity of CYP19A1 protein | CTD | PMID:15070871 |
| DDE | increases expression | ISO | RGD:1606587 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of CYP19A1 mRNA | CTD | PMID:20924025 |
| DDE | decreases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of CYP19A1 mRNA | CTD | PMID:12035542 |
| DDE | multiple interactions | ISO | RGD:1606587 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of and results in increased activity of CYP19A1 protein | CTD | PMID:16077170 |
| DDE | increases activity | ISO | RGD:1606587 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased activity of CYP19A1 protein | CTD | PMID:15070871 |
| DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of CYP19A1 mRNA | CTD | PMID:12035542 |
| dehydroepiandrosterone | increases metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein results in increased metabolism of Dehydroepiandrosterone | CTD | PMID:16397352 |
| dehydroepiandrosterone | multiple interactions | ISO | RGD:1606587 | 6480464 | Lipopolysaccharides inhibits the reaction [Dehydroepiandrosterone results in decreased activity of CYP19A1 protein] | CTD | PMID:10657851 |
| dehydroepiandrosterone | decreases activity | ISO | RGD:1606587 | 6480464 | Dehydroepiandrosterone results in decreased activity of CYP19A1 protein | CTD | PMID:10657851 |
| dexamethasone | multiple interactions | ISO | RGD:1606587 | 6480464 | Calcitriol promotes the reaction [Dexamethasone results in increased activity of CYP19A1 protein] | CTD | PMID:15862960 |
| dexamethasone | increases activity | ISO | RGD:1606587 | 6480464 | Dexamethasone results in increased activity of CYP19A1 protein | CTD | PMID:15862960 PMID:16691199 |
| dexamethasone | increases expression | ISO | RGD:1606587 | 6480464 | Dexamethasone results in increased expression of CYP19A1 mRNA | CTD | PMID:15525692 PMID:16691199 |
| dexamethasone | increases activity | ISO | RGD:1606587 | 6480464 | Dexamethasone results in increased activity of CYP19A1 protein | CTD | PMID:16691199 PMID:15862960 |
| dexamethasone | increases expression | ISO | RGD:1606587 | 6480464 | Dexamethasone results in increased expression of CYP19A1 mRNA | CTD | PMID:16691199 PMID:15525692 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CYP19A1 mRNA | CTD | PMID:19560483 |
| dibutylstannane | decreases activity | ISO | RGD:1606587 | 6480464 | di-n-butyltin analog results in decreased activity of CYP19A1 protein | CTD | PMID:11751016 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of CYP19A1 mRNA | CTD | PMID:18636392 |
| dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of CYP19A1 mRNA | CTD | PMID:18636392 |
| dicofol | decreases activity | ISO | RGD:1606587 | 6480464 | Dicofol results in decreased activity of CYP19A1 protein | CTD | PMID:10806373 |
| diethylstilbestrol | multiple interactions | EXP | | 6480464 | Diethylstilbestrol promotes the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:15878960 |
| diethylstilbestrol | increases expression | ISO | RGD:737520 | 6480464 | Diethylstilbestrol results in increased expression of CYP19A1 mRNA | CTD | PMID:22100434 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CYP19A1 protein; more ... | CTD | PMID:15525594 |
| dipentyl phthalate | increases expression | EXP | | 6480464 | di-n-pentyl phthalate results in increased expression of CYP19A1 mRNA | CTD | PMID:19560483 |
| disulfiram | multiple interactions | ISO | RGD:737520 | 6480464 | Disulfiram inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP19A1 mRNA] | CTD | PMID:22285649 |
| docetaxel anhydrous | decreases expression | ISO | RGD:1606587 | 6480464 | docetaxel results in decreased expression of CYP19A1 mRNA | CTD | PMID:15623590 |
| endosulfan | increases activity | ISO | RGD:1606587 | 6480464 | Endosulfan results in increased activity of CYP19A1 protein | CTD | PMID:16996190 |
| erythrosine sodium | decreases activity | EXP | | 6480464 | Erythrosine results in decreased activity of CYP19A1 protein | CTD | PMID:18310892 |
| estriol | multiple interactions | ISO | RGD:1606587 | 6480464 | Estriol inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA] | CTD | PMID:21296134 |
| estriol | decreases expression | ISO | RGD:1606587 | 6480464 | Estriol results in decreased expression of CYP19A1 mRNA | CTD | PMID:21296134 |
| estrone | affects chemical synthesis | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the chemical synthesis of Estrone | CTD | PMID:16030167 |
| estrone | multiple interactions | ISO | RGD:1606587 | 6480464 | TNF protein promotes the reaction [CYP19A1 protein affects the chemical synthesis of Estrone] | CTD | PMID:16030167 |
| estrone | multiple interactions | ISO | RGD:1606587 | 6480464 | Estrone analog binds to and results in decreased activity of CYP19A1 protein | CTD | PMID:16039845 |
| estrone | increases chemical synthesis | ISO | RGD:1606587 | 6480464 | CYP19A1 protein results in increased chemical synthesis of Estrone | CTD | PMID:16054388 |
| ethosuximide | decreases activity | ISO | RGD:1606587 | 6480464 | Ethosuximide results in decreased activity of CYP19A1 protein | CTD | PMID:17959350 |
| exemestane | decreases activity | ISO | RGD:1606587 | 6480464 | exemestane results in decreased activity of CYP19A1 protein | CTD | PMID:15909811 more ... |
| exemestane | decreases activity | ISO | RGD:1606587 | 6480464 | exemestane results in decreased activity of CYP19A1 protein | CTD | PMID:15837728 more ... |
| exemestane | decreases activity | ISO | RGD:1606587 | 6480464 | exemestane results in decreased activity of CYP19A1 protein | CTD | PMID:16054421 more ... |
| exemestane | decreases activity | ISO | RGD:1606587 | 6480464 | exemestane results in decreased activity of CYP19A1 protein | CTD | PMID:16054421 more ... |
| exemestane | decreases activity | ISO | RGD:1606587 | 6480464 | exemestane results in decreased activity of CYP19A1 protein | CTD | PMID:16034487 more ... |
| exemestane | decreases activity | ISO | RGD:1606587 | 6480464 | exemestane results in decreased activity of CYP19A1 protein | CTD | PMID:15909811 more ... |
| farnesol | increases activity | EXP | | 6480464 | Farnesol results in increased activity of CYP19A1 protein | CTD | PMID:15840382 |
| finasteride | multiple interactions | EXP | | 6480464 | Finasteride promotes the reaction [Androstenedione results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:21273442 |
| flavone | increases activity | ISO | RGD:1606587 | 6480464 | flavone results in increased activity of CYP19A1 protein | CTD | PMID:15319488 |
| fulvestrant | decreases activity | ISO | RGD:1606587 | 6480464 | fulvestrant results in decreased activity of CYP19A1 protein | CTD | PMID:11850205 PMID:15976552 |
| fulvestrant | decreases activity | ISO | RGD:1606587 | 6480464 | fulvestrant results in decreased activity of CYP19A1 protein | CTD | PMID:15976552 PMID:11850205 |
| gallic acid | decreases activity | EXP | | 6480464 | Gallic Acid results in decreased activity of CYP19A1 protein | CTD | PMID:18310892 |
| gamma-hexachlorocyclohexane | multiple interactions | ISO | RGD:1606587 | 6480464 | Lindane inhibits the reaction [Forskolin results in increased expression of CYP19A1 mRNA] | CTD | PMID:17080404 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:1606587 | 6480464 | Lindane results in increased expression of CYP19A1 mRNA | CTD | PMID:17080404 |
| gamma-hexachlorocyclohexane | increases activity | ISO | RGD:1606587 | 6480464 | Lindane results in increased activity of CYP19A1 protein | CTD | PMID:12849724 |
| gamma-hexachlorocyclohexane | decreases activity | ISO | RGD:1606587 | 6480464 | Lindane results in decreased activity of CYP19A1 protein | CTD | PMID:12849724 |
| genistein | multiple interactions | ISO | RGD:1606587 | 6480464 | [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein; more ... | CTD | PMID:16965912 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CYP19A1 mRNA | CTD | PMID:12035542 |
| genistein | decreases activity | ISO | RGD:1606587 | 6480464 | Genistein results in decreased activity of CYP19A1 protein | CTD | PMID:15876411 more ... |
| genistein | increases expression | ISO | RGD:1606587 | 6480464 | Genistein results in increased expression of CYP19A1 protein | CTD | PMID:21854827 |
| genistein | increases expression | ISO | RGD:1606587 | 6480464 | Genistein results in increased expression of CYP19A1 mRNA | CTD | PMID:19549922 PMID:15319488 |
| genistein | multiple interactions | ISO | RGD:1606587 | 6480464 | Genistein inhibits the reaction [Fadrozole results in increased activity of CYP19A1 protein] | CTD | PMID:21854827 |
| genistein | decreases activity | ISO | RGD:1606587 | 6480464 | Genistein results in decreased activity of CYP19A1 protein | CTD | PMID:15876411 more ... |
| genistein | decreases activity | ISO | RGD:1606587 | 6480464 | Genistein results in decreased activity of CYP19A1 protein | CTD | PMID:16965912 more ... |
| genistein | decreases activity | ISO | RGD:1606587 | 6480464 | Genistein results in decreased activity of CYP19A1 protein | CTD | PMID:16023337 more ... |
| genistein | increases activity | ISO | RGD:1606587 | 6480464 | Genistein results in increased activity of CYP19A1 protein | CTD | PMID:15319488 |
| genistein | increases expression | ISO | RGD:1606587 | 6480464 | Genistein results in increased expression of CYP19A1 mRNA | CTD | PMID:15319488 PMID:19549922 |
| genistein | decreases expression | ISO | RGD:1606587 | 6480464 | Genistein results in decreased expression of CYP19A1 mRNA | CTD | PMID:16965912 |
| genistein | decreases activity | ISO | RGD:1606587 | 6480464 | Genistein results in decreased activity of CYP19A1 protein | CTD | PMID:16965912 more ... |
| heptachlor | decreases activity | ISO | RGD:1606587 | 6480464 | Heptachlor results in decreased activity of CYP19A1 protein | CTD | PMID:16996190 |
| hesperetin | decreases activity | ISO | RGD:1606587 | 6480464 | hesperetin results in decreased activity of CYP19A1 protein | CTD | PMID:10403137 |
| ibuprofen | decreases activity | ISO | RGD:1606587 | 6480464 | Ibuprofen results in decreased activity of CYP19A1 protein | CTD | PMID:15964185 |
| ibuprofen | decreases expression | ISO | RGD:1606587 | 6480464 | Ibuprofen results in decreased expression of CYP19A1 mRNA | CTD | PMID:15964185 |
| indomethacin | decreases activity | ISO | RGD:1606587 | 6480464 | Indomethacin results in decreased activity of CYP19A1 protein | CTD | PMID:15964185 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CYP19A1 mRNA | CTD | PMID:18299717 |
| indomethacin | decreases expression | ISO | RGD:1606587 | 6480464 | Indomethacin results in decreased expression of CYP19A1 mRNA | CTD | PMID:15964185 |
| iprodione | increases activity | ISO | RGD:1606587 | 6480464 | iprodione results in increased activity of CYP19A1 protein | CTD | PMID:11884232 |
| L-ascorbic acid | multiple interactions | ISO | RGD:1606587 | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of CYP19A1 mRNA | CTD | PMID:16443354 |
| L-ascorbic acid | increases expression | ISO | RGD:1606587 | 6480464 | Ascorbic Acid results in increased expression of CYP19A1 mRNA | CTD | PMID:17901237 |
| lamotrigine | decreases activity | ISO | RGD:1606587 | 6480464 | lamotrigine results in decreased activity of CYP19A1 protein | CTD | PMID:17959350 |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16023854 more ... |
| letrozole | increases activity | ISO | RGD:1606587 | 6480464 | letrozole results in increased activity of CYP19A1 protein | CTD | PMID:20087668 |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:15837728 more ... |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16034487 more ... |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:15909811 more ... |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16013988 more ... |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16046582 more ... |
| letrozole | decreases activity | ISO | RGD:1606587 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:16034487 more ... |
| letrozole | decreases activity | ISO | RGD:737520 | 6480464 | letrozole results in decreased activity of CYP19A1 protein | CTD | PMID:15967659 |
| leuprolide | multiple interactions | ISO | RGD:737520 | 6480464 | [Leuprolide co-treated with Testosterone] results in decreased expression of CYP19A1 mRNA | CTD | PMID:16032706 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of and results in increased activity of CYP19A1 protein] | CTD | PMID:20096755 |
| LY294002 | multiple interactions | ISO | RGD:1606587 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [o,p'-DDT results in increased expression of CYP19A1 protein] | CTD | PMID:20678559 |
| melatonin | decreases expression | ISO | RGD:1606587 | 6480464 | Melatonin results in decreased expression of CYP19A1 | CTD | PMID:16080194 |
| melatonin | decreases activity | EXP | | 6480464 | Melatonin results in decreased activity of CYP19A1 protein | CTD | PMID:16080194 |
| metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [FSH protein results in increased expression of CYP19A1 protein]; more ... | CTD | PMID:16760380 |
| methadone | multiple interactions | ISO | RGD:1606587 | 6480464 | Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the metabolism of Methadone]; more ... | CTD | PMID:15242824 |
| methadone | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Methadone | CTD | PMID:15242824 |
| methomyl | increases activity | ISO | RGD:1606587 | 6480464 | Methomyl results in increased activity of CYP19A1 protein | CTD | PMID:11884232 |
| methotrexate | affects expression | ISO | RGD:737520 | 6480464 | Methotrexate affects the expression of CYP19A1 mRNA | CTD | PMID:18502557 |
| methotrexate | increases expression | ISO | RGD:1606587 | 6480464 | Methotrexate results in increased expression of CYP19A1 mRNA | CTD | PMID:17400583 |
| methoxychlor | increases activity | ISO | RGD:1606587 | 6480464 | Methoxychlor results in increased activity of CYP19A1 protein | CTD | PMID:16996190 |
| methoxychlor | decreases activity | EXP | | 6480464 | Methoxychlor metabolite results in decreased activity of CYP19A1 protein | CTD | PMID:23326527 |
| methoxychlor | decreases expression | ISO | RGD:737520 | 6480464 | Methoxychlor results in decreased expression of CYP19A1 mRNA | CTD | PMID:21514315 |
| methoxychlor | affects expression | EXP | | 6480464 | Methoxychlor affects the expression of CYP19A1 mRNA | CTD | PMID:22120136 PMID:22285353 |
| methoxychlor | decreases expression | EXP | | 6480464 | Methoxychlor results in decreased expression of CYP19A1 protein | CTD | PMID:22285353 |
| methoxychlor | multiple interactions | EXP | | 6480464 | Methoxychlor inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein] | CTD | PMID:22120136 |
| methoxychlor | affects expression | EXP | | 6480464 | Methoxychlor affects the expression of CYP19A1 mRNA | CTD | PMID:22285353 PMID:22120136 |
| methoxychlor | multiple interactions | ISO | RGD:1606587 | 6480464 | Methoxychlor affects the reaction [CYP19A1 protein results in increased metabolism of Androstenedione] | CTD | PMID:22120136 |
| methoxychlor | affects expression | ISO | RGD:1606587 | 6480464 | Methoxychlor affects the expression of CYP19A1 mRNA | CTD | PMID:22120136 |
| methoxychlor | multiple interactions | EXP | | 6480464 | Methoxychlor metabolite inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA] | CTD | PMID:16737795 |
| methoxychlor | increases expression | ISO | RGD:1606587 | 6480464 | Methoxychlor results in increased expression of CYP19A1 mRNA | CTD | PMID:16996190 |
| methyltestosterone | multiple interactions | ISO | RGD:1606587 | 6480464 | Methyltestosterone inhibits the reaction [CYP19A1 protein affects the metabolism of Androstenedione] | CTD | PMID:12628686 |
| miconazole | decreases activity | ISO | RGD:1606587 | 6480464 | Miconazole results in decreased activity of CYP19A1 protein | CTD | PMID:15554355 |
| mono(2-ethylhexyl) phthalate | decreases activity | ISO | RGD:1606587 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased activity of CYP19A1 protein | CTD | PMID:19501113 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:737520 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19874833 PMID:22401849 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1606587 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19501113 PMID:22401849 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1606587 | 6480464 | mono-(2-ethylhexyl)phthalate inhibits the reaction [Forskolin results in increased expression of CYP19A1 mRNA] | CTD | PMID:19822197 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:737520 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19874833 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1606587 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA | CTD | PMID:19501113 |
| nandrolone | multiple interactions | ISO | RGD:1606587 | 6480464 | Nandrolone inhibits the reaction [CYP19A1 protein affects the metabolism of Androstenedione] | CTD | PMID:12628686 |
| nimesulide | decreases activity | ISO | RGD:1606587 | 6480464 | nimesulide analog results in decreased activity of CYP19A1 protein | CTD | PMID:20542113 |
| nimesulide | decreases expression | ISO | RGD:1606587 | 6480464 | nimesulide results in decreased expression of CYP19A1 mRNA | CTD | PMID:15964185 |
| nimesulide | decreases activity | ISO | RGD:1606587 | 6480464 | nimesulide results in decreased activity of CYP19A1 protein | CTD | PMID:15964185 |
| nimesulide | decreases expression | ISO | RGD:1606587 | 6480464 | nimesulide analog results in decreased expression of CYP19A1 mRNA | CTD | PMID:20542113 |
| nimesulide | decreases activity | ISO | RGD:1606587 | 6480464 | nimesulide results in decreased activity of CYP19A1 | CTD | PMID:17315855 |
| nimesulide | multiple interactions | ISO | RGD:1606587 | 6480464 | nimesulide analog results in decreased activity of and results in decreased expression of CYP19A1 | CTD | PMID:17315855 |
| oxcarbazepine | decreases activity | ISO | RGD:1606587 | 6480464 | oxcarbazepine results in decreased activity of CYP19A1 protein | CTD | PMID:17959350 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of CYP19A1 mRNA | CTD | PMID:18636392 |
| paclitaxel | increases activity | ISO | RGD:1606587 | 6480464 | Paclitaxel results in increased activity of CYP19A1 protein | CTD | PMID:14691014 |
| parathion-methyl | increases activity | ISO | RGD:1606587 | 6480464 | Methyl Parathion results in increased activity of CYP19A1 protein | CTD | PMID:16996190 |
| pentachlorophenol | decreases expression | ISO | RGD:1606587 | 6480464 | Pentachlorophenol results in decreased expression of CYP19A1 mRNA | CTD | PMID:21296122 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:737520 | 6480464 | [perfluorooctanoic acid co-treated with PPARA] results in increased expression of CYP19A1 mRNA | CTD | PMID:20118188 |
| perfluorooctanoic acid | decreases activity | EXP | | 6480464 | perfluorooctanoic acid results in decreased activity of CYP19A1 protein | CTD | PMID:8812269 |
| perfluorooctanoic acid | increases activity | EXP | | 6480464 | perfluorooctanoic acid results in increased activity of CYP19A1 protein | CTD | PMID:8812269 |
| phenobarbital | multiple interactions | ISO | RGD:1606587 | 6480464 | Phenobarbital promotes the reaction [Valproic Acid results in decreased activity of CYP19A1 protein] | CTD | PMID:17959350 |
| phenobarbital | decreases activity | ISO | RGD:1606587 | 6480464 | Phenobarbital results in decreased activity of CYP19A1 protein | CTD | PMID:17959350 |
| phenytoin | decreases activity | ISO | RGD:1606587 | 6480464 | Phenytoin results in decreased activity of CYP19A1 protein | CTD | PMID:17959350 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1606587 | 6480464 | alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Forskolin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] | CTD | PMID:16357189 |
| phorbol 13-acetate 12-myristate | decreases activity | ISO | RGD:1606587 | 6480464 | Tetradecanoylphorbol Acetate results in decreased activity of CYP19A1 protein | CTD | PMID:10338361 |
| pirimicarb | increases activity | ISO | RGD:1606587 | 6480464 | pirimicarb results in increased activity of CYP19A1 protein | CTD | PMID:11884232 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CYP19A1 mRNA | CTD | PMID:19162173 |
| piroxicam | multiple interactions | ISO | RGD:1606587 | 6480464 | Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA] | CTD | PMID:19147701 |
| piroxicam | decreases expression | ISO | RGD:1606587 | 6480464 | Piroxicam results in decreased expression of CYP19A1 mRNA | CTD | PMID:15964185 |
| piroxicam | decreases activity | ISO | RGD:1606587 | 6480464 | Piroxicam results in decreased activity of CYP19A1 protein | CTD | PMID:15964185 |
| profenofos | decreases expression | EXP | | 6480464 | profenofos results in decreased expression of CYP19A1 mRNA | CTD | PMID:18828448 |
| progesterone | increases activity | ISO | RGD:1606587 | 6480464 | Progesterone results in increased activity of CYP19A1 protein | CTD | PMID:15862960 |
| propazine | multiple interactions | ISO | RGD:1606587 | 6480464 | formestane inhibits the reaction [propazine results in increased activity of CYP19A1 protein] | CTD | PMID:10746939 |
| propazine | increases activity | ISO | RGD:1606587 | 6480464 | propazine results in increased activity of CYP19A1 protein | CTD | PMID:10746939 PMID:11675267 |
| propazine | increases expression | ISO | RGD:1606587 | 6480464 | propazine results in increased expression of CYP19A1 mRNA | CTD | PMID:10746939 PMID:11675267 |
| propazine | increases expression | ISO | RGD:1606587 | 6480464 | propazine results in increased expression of CYP19A1 mRNA | CTD | PMID:11675267 PMID:10746939 |
| propazine | increases activity | ISO | RGD:1606587 | 6480464 | propazine results in increased activity of CYP19A1 protein | CTD | PMID:11675267 PMID:10746939 |
| propiconazole | decreases activity | ISO | RGD:1606587 | 6480464 | propiconazole results in decreased activity of CYP19A1 protein | CTD | PMID:16996190 |
| prostaglandin E2 | multiple interactions | ISO | RGD:1606587 | 6480464 | 2-methoxyoestrone-3-O-sulphamate inhibits the reaction [Dinoprostone results in increased activity of CYP19A1 protein] | CTD | PMID:15862962 |
| prostaglandin E2 | increases expression | ISO | RGD:1606587 | 6480464 | Dinoprostone results in increased expression of CYP19A1 protein | CTD | PMID:20678559 |
| prostaglandin E2 | increases expression | ISO | RGD:1606587 | 6480464 | Dinoprostone results in increased expression of CYP19A1 mRNA | CTD | PMID:16024248 PMID:20678559 |
| prostaglandin E2 | increases activity | ISO | RGD:1606587 | 6480464 | Dinoprostone results in increased activity of CYP19A1 protein | CTD | PMID:15862962 PMID:16024248 |
| prostaglandin E2 | increases expression | ISO | RGD:1606587 | 6480464 | Dinoprostone results in increased expression of CYP19A1 mRNA | CTD | PMID:16024248 |
| prostaglandin E2 | increases activity | ISO | RGD:1606587 | 6480464 | Dinoprostone results in increased activity of CYP19A1 protein | CTD | PMID:16024248 PMID:15862962 |
| prostaglandin F2alpha | decreases expression | ISO | RGD:737520 | 6480464 | Dinoprost results in decreased expression of CYP19A1 mRNA | CTD | PMID:15271885 |
| prostaglandin F2alpha | decreases expression | EXP | | 6480464 | Dinoprost results in decreased expression of CYP19A1 mRNA | CTD | PMID:11517196 PMID:15271885 |
| prostaglandin F2alpha | decreases expression | EXP | | 6480464 | Dinoprost results in decreased expression of CYP19A1 mRNA | CTD | PMID:15271885 PMID:11517196 |
| prostaglandin F2alpha | multiple interactions | EXP | | 6480464 | Dinoprost promotes the reaction [GATA4 protein binds to CYP19A1 promoter] | CTD | PMID:15271885 |
| prostaglandin F2alpha | decreases expression | EXP | | 6480464 | Dinoprost results in decreased expression of CYP19A1 protein; more ... | CTD | PMID:15271885 |
| quercetin | decreases expression | ISO | RGD:1606587 | 6480464 | Quercetin results in decreased expression of CYP19A1 mRNA | CTD | PMID:16965912 |
| quercetin | decreases expression | ISO | RGD:1606587 | 6480464 | Quercetin results in decreased expression of CYP19A1 mRNA | CTD | PMID:16965912 PMID:21632981 |
| quercetin | decreases activity | ISO | RGD:1606587 | 6480464 | Quercetin results in decreased activity of CYP19A1 protein | CTD | PMID:16023337 PMID:16965912 |
| quercetin | increases activity | ISO | RGD:1606587 | 6480464 | Quercetin results in increased activity of CYP19A1 protein | CTD | PMID:15319488 |
| quercetin | increases expression | ISO | RGD:1606587 | 6480464 | Quercetin results in increased expression of CYP19A1 mRNA | CTD | PMID:15319488 |
| quercetin | decreases activity | ISO | RGD:1606587 | 6480464 | Quercetin results in decreased activity of CYP19A1 protein | CTD | PMID:16965912 PMID:16023337 |
| raloxifene | multiple interactions | ISO | RGD:1606587 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in decreased expression of CYP19A1 mRNA | CTD | PMID:19059307 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:22357324 |
| resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:16611627 more ... |
| resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol metabolite results in decreased activity of CYP19A1 protein | CTD | PMID:20527891 |
| resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:16611627 more ... |
| resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:16611627 more ... |
| resveratrol | decreases expression | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased expression of CYP19A1 mRNA | CTD | PMID:17766065 PMID:16611627 |
| resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:17766065 more ... |
| resveratrol | decreases expression | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased expression of CYP19A1 mRNA | CTD | PMID:16611627 PMID:17766065 |
| resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:17910019 more ... |
| rose bengal | decreases activity | EXP | | 6480464 | Rose Bengal results in decreased activity of CYP19A1 protein | CTD | PMID:18310892 |
| rotenone | decreases activity | ISO | RGD:1606587 | 6480464 | Rotenone results in decreased activity of CYP19A1 protein | CTD | PMID:15319488 |
| semicarbazide | increases activity | EXP | | 6480464 | carbamylhydrazine results in increased activity of CYP19A1 protein | CTD | PMID:19788891 |
| semicarbazide | multiple interactions | EXP | | 6480464 | [carbamylhydrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone metabolite | CTD | PMID:19788891 |
| simazine | multiple interactions | ISO | RGD:1606587 | 6480464 | formestane inhibits the reaction [Simazine results in increased activity of CYP19A1 protein] | CTD | PMID:10746939 |
| simazine | increases expression | ISO | RGD:1606587 | 6480464 | Simazine results in increased expression of CYP19A1 mRNA | CTD | PMID:11675267 PMID:10746939 |
| simazine | increases activity | ISO | RGD:1606587 | 6480464 | Simazine results in increased activity of CYP19A1 protein | CTD | PMID:10746939 PMID:11675267 |
| simazine | increases expression | ISO | RGD:1606587 | 6480464 | Simazine results in increased expression of CYP19A1 mRNA | CTD | PMID:10746939 PMID:11675267 |
| simazine | increases activity | ISO | RGD:1606587 | 6480464 | Simazine results in increased activity of CYP19A1 protein | CTD | PMID:11675267 PMID:10746939 |
| tamoxifen | increases expression | ISO | RGD:1606587 | 6480464 | Tamoxifen analog results in increased expression of CYP19A1 mRNA | CTD | PMID:19549922 |
| tamoxifen | decreases expression | ISO | RGD:1606587 | 6480464 | Tamoxifen results in decreased expression of CYP19A1 mRNA | CTD | PMID:21296134 |
| tamoxifen | multiple interactions | ISO | RGD:1606587 | 6480464 | Tamoxifen inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA]; more ... | CTD | PMID:21296134 |
| tamoxifen | multiple interactions | ISO | RGD:1606587 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP19A1 mRNA | CTD | PMID:19059307 |
| testolactone | decreases activity | ISO | RGD:1606587 | 6480464 | Testolactone results in decreased activity of CYP19A1 protein | CTD | PMID:16026110 |
| testosterone | affects abundance | ISO | RGD:1606587 | 6480464 | CYP19A1 gene SNP affects the abundance of Testosterone | CTD | PMID:16949385 |
| testosterone | multiple interactions | ISO | RGD:1606587 | 6480464 | [Atrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone; more ... | CTD | PMID:20087668 |
| testosterone | multiple interactions | ISO | RGD:737520 | 6480464 | Disulfiram inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP19A1 mRNA] | CTD | PMID:22285649 |
| testosterone | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Testosterone | CTD | PMID:11751016 more ... |
| testosterone | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Testosterone | CTD | PMID:16054388 more ... |
| testosterone | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Testosterone | CTD | PMID:16054388 more ... |
| testosterone | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Testosterone | CTD | PMID:16030167 more ... |
| testosterone | multiple interactions | EXP | | 6480464 | [carbamylhydrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone metabolite | CTD | PMID:19788891 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of CYP19A1 protein; more ... | CTD | PMID:15525594 PMID:21273442 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:21273442 PMID:15525594 |
| testosterone | increases metabolic processing | EXP | | 6480464 | CYP19A1 protein results in increased metabolism of Testosterone | CTD | PMID:16569475 |
| testosterone | affects metabolic processing | EXP | | 6480464 | CYP19A1 protein affects the metabolism of Testosterone | CTD | PMID:16080194 |
| testosterone | decreases expression | ISO | RGD:737520 | 6480464 | Testosterone results in decreased expression of CYP19A1 mRNA | CTD | PMID:20600201 |
| testosterone | multiple interactions | EXP | | 6480464 | AR mutant form inhibits the reaction [Testosterone results in increased expression of CYP19A1 protein]; more ... | CTD | PMID:21273442 |
| testosterone | multiple interactions | ISO | RGD:1606587 | 6480464 | tributyltin inhibits the reaction [CYP19A1 protein affects the metabolism of Testosterone] | CTD | PMID:11751016 |
| testosterone | multiple interactions | ISO | RGD:1606587 | 6480464 | TNF protein promotes the reaction [CYP19A1 protein affects the metabolism of Testosterone] | CTD | PMID:16030167 |
| testosterone | multiple interactions | ISO | RGD:737520 | 6480464 | [Leuprolide co-treated with Testosterone] results in decreased expression of CYP19A1 mRNA | CTD | PMID:16032706 |
| testosterone | multiple interactions | ISO | RGD:1606587 | 6480464 | Testosterone inhibits the reaction [CYP19A1 protein affects the metabolism of Androstenedione] | CTD | PMID:12628686 |
| testosterone | affects metabolic processing | ISO | RGD:1606587 | 6480464 | CYP19A1 protein affects the metabolism of Testosterone | CTD | PMID:11751016 more ... |
| testosterone enanthate | decreases expression | EXP | | 6480464 | testosterone enanthate results in decreased expression of CYP19A1 mRNA | CTD | PMID:21427060 |
| testosterone enanthate | increases expression | EXP | | 6480464 | testosterone enanthate results in increased expression of CYP19A1 mRNA | CTD | PMID:21427060 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CYP19A1 mRNA; more ... | CTD | PMID:22357324 |
| trans-resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:16611627 more ... |
| trans-resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol metabolite results in decreased activity of CYP19A1 protein | CTD | PMID:20527891 |
| trans-resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:16611627 more ... |
| trans-resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:16611627 more ... |
| trans-resveratrol | decreases expression | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased expression of CYP19A1 mRNA | CTD | PMID:17766065 PMID:16611627 |
| trans-resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:17766065 more ... |
| trans-resveratrol | decreases expression | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased expression of CYP19A1 mRNA | CTD | PMID:16611627 PMID:17766065 |
| trans-resveratrol | decreases activity | ISO | RGD:1606587 | 6480464 | resveratrol results in decreased activity of CYP19A1 protein | CTD | PMID:17910019 more ... |
| tributylstannane | multiple interactions | ISO | RGD:1606587 | 6480464 | [tributyltin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | CTD | PMID:15941851 |
| tributylstannane | increases expression | ISO | RGD:1606587 | 6480464 | tributyltin results in increased expression of CYP19A1 mRNA | CTD | PMID:16996190 PMID:15941851 |
| tributylstannane | decreases activity | ISO | RGD:1606587 | 6480464 | tributyltin results in decreased activity of CYP19A1 protein | CTD | PMID:11751016 PMID:11522339 |
| tributylstannane | decreases activity | EXP | | 6480464 | tributyltin results in decreased activity of CYP19A1 protein | CTD | PMID:18310892 |
| tributylstannane | increases expression | ISO | RGD:1606587 | 6480464 | tributyltin results in increased expression of CYP19A1 mRNA | CTD | PMID:15941851 PMID:16996190 |
| tributylstannane | increases activity | ISO | RGD:1606587 | 6480464 | tributyltin results in increased activity of CYP19A1 protein | CTD | PMID:16996190 |
| tributylstannane | decreases activity | ISO | RGD:1606587 | 6480464 | tributyltin results in decreased activity of CYP19A1 protein | CTD | PMID:11522339 PMID:11751016 |
| tributylstannane | multiple interactions | ISO | RGD:1606587 | 6480464 | tributyltin inhibits the reaction [CYP19A1 protein affects the metabolism of Testosterone] | CTD | PMID:11751016 |
| tributylstannane | multiple interactions | ISO | RGD:1606587 | 6480464 | tributyltin inhibits the reaction [CYP19A1 protein binds to and results in increased metabolism of Androstenedione] | CTD | PMID:11522339 |
| triphenylstannane | affects activity | EXP | | 6480464 | triphenyltin affects the activity of CYP19A1 protein | CTD | PMID:20708649 |
| triphenylstannanol | multiple interactions | ISO | RGD:1606587 | 6480464 | [triphenyltin hydroxide binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | CTD | PMID:15941851 |
| triphenylstannanol | increases expression | ISO | RGD:1606587 | 6480464 | triphenyltin hydroxide results in increased expression of CYP19A1 mRNA | CTD | PMID:15941851 |
| tris(2-chloroethyl) phosphate | increases expression | ISO | RGD:1606587 | 6480464 | tris(chloroethyl)phosphate results in increased expression of CYP19A1 mRNA | CTD | PMID:22446829 |
| troglitazone | multiple interactions | ISO | RGD:1606587 | 6480464 | LG 100268 promotes the reaction [troglitazone results in decreased activity of CYP19A1 mRNA]; more ... | CTD | PMID:10814527 |
| troglitazone | decreases expression | ISO | RGD:1606587 | 6480464 | troglitazone results in decreased expression of CYP19A1 mRNA | CTD | PMID:10814527 |
| troglitazone | decreases activity | ISO | RGD:1606587 | 6480464 | troglitazone results in decreased activity of CYP19A1 protein | CTD | PMID:10814527 |
| valproic acid | decreases activity | ISO | RGD:1606587 | 6480464 | Valproic Acid results in decreased activity of CYP19A1 protein | CTD | PMID:17959350 |
| valproic acid | multiple interactions | ISO | RGD:1606587 | 6480464 | Phenobarbital promotes the reaction [Valproic Acid results in decreased activity of CYP19A1 protein] | CTD | PMID:17959350 |
| zearalenone | decreases activity | ISO | RGD:1606587 | 6480464 | Zearalenone results in decreased activity of CYP19A1 protein | CTD | PMID:16023337 |